[Form 4] Mesa Laboratories Inc Insider Trading Activity
Shannon Hall, a director of Mesa Laboratories, reported stock-based compensation transactions dated 08/15/2025. The filing shows 1,404 restricted stock units (RSUs) vested on that date and were converted into 1,404 shares of common stock with a reported acquisition price of $0. After the transaction Hall beneficially owns 4,189 shares directly. The filing also reports an additional grant of 2,784 RSUs that vest on 08/15/2026 and are recorded as 2,784 shares of underlying common stock. The Form 4 was executed under power of attorney and signed on 08/18/2025.
Shannon Hall, direttore di Mesa Laboratories, ha comunicato operazioni di compenso basato su azioni datate 15/08/2025. La comunicazione indica che 1.404 unit脿 azionarie vincolate (RSU) sono maturate in tale data e sono state convertite in 1.404 azioni ordinarie con prezzo di acquisizione riportato pari a $0. Dopo l'operazione, Hall detiene 4.189 azioni in propriet脿 diretta. Il documento segnala inoltre una concessione aggiuntiva di 2.784 RSU che matureranno il 15/08/2026 e sono registrate come 2.784 azioni ordinarie sottostanti. Il Modulo 4 猫 stato firmato per procura in data 18/08/2025.
Shannon Hall, directora de Mesa Laboratories, inform贸 transacciones de compensaci贸n en acciones con fecha 15/08/2025. El reporte muestra que 1.404 unidades restringidas de acciones (RSU) vencieron en esa fecha y se convirtieron en 1.404 acciones ordinarias con un precio de adquisici贸n informado de $0. Tras la transacci贸n, Hall posee 4.189 acciones en propiedad directa. El formulario tambi茅n informa una concesi贸n adicional de 2.784 RSU que vencer谩n el 15/08/2026 y se registran como 2.784 acciones ordinarias subyacentes. El Formulario 4 fue firmado por poder el 18/08/2025.
Mesa Laboratories鞚� 鞚挫偓 Shannon Hall鞚� 2025雲� 8鞗� 15鞚检瀽 欤检嫕 旮半皹 氤挫儊 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� 頃措嫻 鞚检瀽鞐� 1,404臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)臧� 靹标臣臁瓣贝鞚� 於╈”頃橃棳 1,404欤检潣 氤错喌欤茧 鞝勴櫂霅橃棃瓿� 旆摑臧�電� $0搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 頉� Hall鞚� 歆侅爲 4,189欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 霕愴暅 於旉皜搿� 2,784 RSU臧� 攵�鞐悩鞏� 2026雲� 8鞗� 15鞚�鞐� 靹标臣臧� 頇曥爼霅橂┌ 旮办磮 氤错喌欤� 2,784欤茧 旮半霅橃柎 鞛堧嫟瓿� 氤搓碃霅橃棃鞀惦媹雼�. Form 4電� 鞙勳瀯鞛レ棎 霐半澕 鞛戩劚霅橃柎 2025雲� 8鞗� 18鞚�鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Shannon Hall, administratrice de Mesa Laboratories, a d茅clar茅 des op茅rations de r茅mun茅ration en actions dat茅es du 15/08/2025. Le d茅p么t indique que 1 404 unit茅s d'actions restreintes (RSU) ont acquis 脿 cette date et ont 茅t茅 converties en 1 404 actions ordinaires avec un prix d'acquisition d茅clar茅 de 0 $. Apr猫s la transaction, Hall d茅tient directement 4 189 actions. Le document signale 茅galement une attribution suppl茅mentaire de 2 784 RSU qui acquerront le 15/08/2026 et sont enregistr茅es comme 2 784 actions ordinaires sous-jacentes. Le formulaire 4 a 茅t茅 sign茅 par procuration le 18/08/2025.
Shannon Hall, Direktorin von Mesa Laboratories, meldete aktienbasierte Verg眉tungs-Transaktionen mit Datum 15.08.2025. Die Einreichung zeigt, dass 1.404 Restricted Stock Units (RSUs) an diesem Datum f盲llig wurden und in 1.404 Stammaktien umgewandelt wurden, mit einem angegebenen Erwerbspreis von $0. Nach der Transaktion besitzt Hall direkt 4.189 Aktien. Die Meldung berichtet au脽erdem 眉ber eine zus盲tzliche Zuteilung von 2.784 RSUs, die am 15.08.2026 f盲llig werden und als 2.784 zugrunde liegende Stammaktien erfasst sind. Das Formular 4 wurde per Vollmacht ausgef眉hrt und am 18.08.2025 unterschrieben.
- Timely disclosure of insider transaction with filing executed shortly after the transaction date
- Vested RSUs converted to shares, increasing the reporting person's direct ownership to 4,189 shares
- No cash paid for the vested RSUs as reported (price = $0)
- Future RSUs disclosed with clear vesting date of 08/15/2026
- None.
Insights
TL;DR: Routine RSU vesting increased a director's direct share count by 1,404 shares; no cash paid.
The transaction reflects standard equity compensation mechanics rather than a market-moving event. The vested RSUs converted to 1,404 shares at a reported price of $0, increasing Shannon Hall's direct holdings to 4,189 shares. An additional 2,784 RSUs remain scheduled to vest on 08/15/2026, representing future dilution when settled. For investors, this is a disclosure of insider alignment via equity compensation, but the absolute size is small relative to public-company float and does not indicate a change in company operations or financial condition.
TL;DR: This is a standard director equity vesting disclosure; timing and POA signature are properly documented.
The Form 4 documents customary rollout of restricted stock units to a director with clear vesting dates and an executed filing under power of attorney. The filing shows no sale or cash purchase; vested units converted into shares and additional RSUs remain outstanding with a one-year vesting horizon. From a governance perspective the filing demonstrates routine director compensation and timely reporting, with no red flags such as accelerated dispositions or unexpected changes in control.
Shannon Hall, direttore di Mesa Laboratories, ha comunicato operazioni di compenso basato su azioni datate 15/08/2025. La comunicazione indica che 1.404 unit脿 azionarie vincolate (RSU) sono maturate in tale data e sono state convertite in 1.404 azioni ordinarie con prezzo di acquisizione riportato pari a $0. Dopo l'operazione, Hall detiene 4.189 azioni in propriet脿 diretta. Il documento segnala inoltre una concessione aggiuntiva di 2.784 RSU che matureranno il 15/08/2026 e sono registrate come 2.784 azioni ordinarie sottostanti. Il Modulo 4 猫 stato firmato per procura in data 18/08/2025.
Shannon Hall, directora de Mesa Laboratories, inform贸 transacciones de compensaci贸n en acciones con fecha 15/08/2025. El reporte muestra que 1.404 unidades restringidas de acciones (RSU) vencieron en esa fecha y se convirtieron en 1.404 acciones ordinarias con un precio de adquisici贸n informado de $0. Tras la transacci贸n, Hall posee 4.189 acciones en propiedad directa. El formulario tambi茅n informa una concesi贸n adicional de 2.784 RSU que vencer谩n el 15/08/2026 y se registran como 2.784 acciones ordinarias subyacentes. El Formulario 4 fue firmado por poder el 18/08/2025.
Mesa Laboratories鞚� 鞚挫偓 Shannon Hall鞚� 2025雲� 8鞗� 15鞚检瀽 欤检嫕 旮半皹 氤挫儊 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� 頃措嫻 鞚检瀽鞐� 1,404臧滌潣 鞝滍暅攵�欤检嫕雼渼(RSU)臧� 靹标臣臁瓣贝鞚� 於╈”頃橃棳 1,404欤检潣 氤错喌欤茧 鞝勴櫂霅橃棃瓿� 旆摑臧�電� $0搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 瓯半灅 頉� Hall鞚� 歆侅爲 4,189欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 霕愴暅 於旉皜搿� 2,784 RSU臧� 攵�鞐悩鞏� 2026雲� 8鞗� 15鞚�鞐� 靹标臣臧� 頇曥爼霅橂┌ 旮办磮 氤错喌欤� 2,784欤茧 旮半霅橃柎 鞛堧嫟瓿� 氤搓碃霅橃棃鞀惦媹雼�. Form 4電� 鞙勳瀯鞛レ棎 霐半澕 鞛戩劚霅橃柎 2025雲� 8鞗� 18鞚�鞐� 靹滊獏霅橃棃鞀惦媹雼�.
Shannon Hall, administratrice de Mesa Laboratories, a d茅clar茅 des op茅rations de r茅mun茅ration en actions dat茅es du 15/08/2025. Le d茅p么t indique que 1 404 unit茅s d'actions restreintes (RSU) ont acquis 脿 cette date et ont 茅t茅 converties en 1 404 actions ordinaires avec un prix d'acquisition d茅clar茅 de 0 $. Apr猫s la transaction, Hall d茅tient directement 4 189 actions. Le document signale 茅galement une attribution suppl茅mentaire de 2 784 RSU qui acquerront le 15/08/2026 et sont enregistr茅es comme 2 784 actions ordinaires sous-jacentes. Le formulaire 4 a 茅t茅 sign茅 par procuration le 18/08/2025.
Shannon Hall, Direktorin von Mesa Laboratories, meldete aktienbasierte Verg眉tungs-Transaktionen mit Datum 15.08.2025. Die Einreichung zeigt, dass 1.404 Restricted Stock Units (RSUs) an diesem Datum f盲llig wurden und in 1.404 Stammaktien umgewandelt wurden, mit einem angegebenen Erwerbspreis von $0. Nach der Transaktion besitzt Hall direkt 4.189 Aktien. Die Meldung berichtet au脽erdem 眉ber eine zus盲tzliche Zuteilung von 2.784 RSUs, die am 15.08.2026 f盲llig werden und als 2.784 zugrunde liegende Stammaktien erfasst sind. Das Formular 4 wurde per Vollmacht ausgef眉hrt und am 18.08.2025 unterschrieben.
FAQ
What did Shannon Hall report on Form 4 for MLAB?
Did Shannon Hall purchase shares on 08/15/2025 for MLAB?
Are there additional RSUs disclosed for Shannon Hall?
What is the reporting person鈥檚 relationship to Mesa Laboratories (MLAB)?
When was the Form 4 signed and who signed it?
